top of page
SpotLight
Top stories from around the world
Life & Healthcare
'AbbVie to Buy Capstan Therapeutics for up to $2.1 Billion' - US News Money
AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion
Jul 3
Primary Health Properties: Assura board backs £1.79bn takeover bid - Hargreaves Lansdown
Primary Health Properties has won the bidding war for Assura, as the Assura board recommends an improved £1.79bn offer to its shareholders.
Jun 23
'UK's Assura shares rise on $2.08 billion bid from KKR, Stonepeak' - Reuters
Assura said on Monday it would consider a 1.61 billion pound ($2.1 billion) offer from U.S. private equity group KKR
Mar 10
bottom of page